ReiThera vs Thermo Fisher Scientific: CDMO Comparison

How does ReiThera compare to Thermo Fisher Scientific?

As of Mar 2026, ReiThera: no FDA inspections on file, 4 EMA/MHRA GMP certificates. Signal Score 71.1. Thermo Fisher Scientific: 19 FDA inspections (including 6 NAI, 13 VAI and 0 OAI), 10 EMA/MHRA GMP certificates. Signal Score 77.6. Counts are the established FDA, EMA and MHRA records on each profile. CDMOs cannot pay to change a score.

Side-by-side comparison of ReiThera and Thermo Fisher Scientific on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.

Rome, IT
Signal Score
71/100
Quality (FDA + GMP)
100/100
FDA inspections
0
FDA warning letters
0
EMA GMP certificates (active)
4
MHRA GMP certificates (compliant)
0
Clinical programs (matched)
1
Capacity
—
Modalities
Adenoviral, AAV
Plainville, MA · Alachua, FL · Cambridge, MA
Signal Score
78/100
Quality (FDA + GMP)
93/100
FDA inspections
19
— NAI / VAI / OAI
6 / 13 / 0
FDA warning letters
0
EMA GMP certificates (active)
1
MHRA GMP certificates (compliant)
9
Clinical programs (matched)
2
Capacity
Available
Modalities
AAV, Lentiviral, Plasmid DNA, Adenoviral, Plasmid, Small Molecule API, Oral Solid Dose, Sterile Fill-Finish

Key differences

  • Thermo Fisher Scientific has more FDA inspections on record (19 vs 0) — a deeper regulatory paper trail.
  • Both maintain clean enforcement records — no FDA OAI classifications or warning letters on file for either CDMO.
  • ReiThera has materially broader EMA GMP coverage (4 active certificates vs 1) — stronger EU footprint.
  • Thermo Fisher Scientific maintains 9 MHRA / UK GMP certificates; ReiThera does not.

Across the cross-modality scorecard, Thermo Fisher Scientific carries the higher composite Signal Score — but the right choice depends on the specific modality, phase, and geography of the program.

Frequently asked: ReiThera vs Thermo Fisher Scientific

How does ReiThera compare to Thermo Fisher Scientific?

On CDMO Signal's composite Signal Score, ReiThera is 71/100 and Thermo Fisher Scientific is 78/100; ReiThera has 0 FDA inspections on record vs 19 for Thermo Fisher Scientific; European coverage is 4 active EMA+MHRA certificates for ReiThera vs 10 for Thermo Fisher Scientific. Both are tracked in the CDMO Signal directory. The scorecard above breaks down every metric side by side — use it alongside each CDMO's individual profile for the full regulatory and clinical footprint.

Which has the stronger FDA inspection record, ReiThera or Thermo Fisher Scientific?

Both ReiThera and Thermo Fisher Scientific maintain clean enforcement records on file — no FDA warning letters and no OAI classifications. ReiThera has 0 FDA inspections on record; Thermo Fisher Scientific has 19.

How do ReiThera and Thermo Fisher Scientific compare on European GMP coverage?

ReiThera holds 4 active EMA GMP certificates and 0 MHRA / UK certificates. Thermo Fisher Scientific holds 1 active EMA GMP certificate and 9 MHRA / UK certificates. Use these counts as a proxy for the breadth of each CDMO's European regulatory footprint.

Which is more active in clinical-stage manufacturing — ReiThera or Thermo Fisher Scientific?

ReiThera is matched to 1 ClinicalTrials.gov record as a manufacturing partner; Thermo Fisher Scientific is matched to 2. Higher counts indicate broader sponsor exposure but say nothing about approved-product track record — pair this number with each CDMO's profile page for context.

What does the Signal Score gap mean in practice?

ReiThera carries a Signal Score of 71/100 and Thermo Fisher Scientific carries 78/100 — a small lead for Thermo Fisher Scientific. The Signal Score combines quality (FDA inspections + EMA/MHRA GMP), operational performance, financial stability, and capacity intelligence. CDMOs cannot pay to influence their score.

Evaluating ReiThera and Thermo Fisher Scientific for a program?

Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.

Find & compare CDMOs →
Sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.